Richard Allan Davies

Senioringeniør

Vis forfatter(e) (2022). Aberrant signaling of immune cells in Sjögren's syndrome patient subgroups upon interferon stimulation. Frontiers in Immunology. 13 sider.

Vis forfatter(e) (2021). Humoral and cellular immune responses in critically ill influenza A/H1N1-infected patients. Scandinavian Journal of Immunology. 1-9.

Vis forfatter(e) (2019). Single cell based phosphorylation profiling identifies alterations in toll-like receptor 7 and 9 signaling in patients with primary sjogren's syndrome. Frontiers in Immunology. 1-18.

Vis forfatter(e) (2018). Phosphorylation of intracellular signaling molecules in peripheral blood cells from psoriasis patients on originator or biosimilar infliximab. British Journal of Dermatology. 371-380.
Vis forfatter(e) (2018). Improving influenza vaccines: challenges to effective implementation. Current Opinion in Immunology. 88-95.
Vis forfatter(e) (2018). Aberrant cell signalling in PBMCs upon IFN-? stimulation in primary Sjogren's syndrome patients associates with type I interferon signature. European Journal of Immunology. 1217-1227.

Vis forfatter(e) (2017). Patients with primary Sjögren's syndrome have alterations in absolute quantities of specific peripheral leucocyte populations. Scandinavian Journal of Immunology. 491-502.
Vis forfatter(e) (2017). Flow cytometry based analyses as a tool in biomarker discovery for patient stratification in primary Sjögren’s syndrome.